Biofrontera AG buy krebskrebs
Start price
16.08.21
/
50%
€2.49
Target price
16.08.22
€4.00
Performance (%)
-50.80%
End price
17.08.22
€1.23
Summary
This prediction ended on 17.08.22 with a price of €1.23. Massive losses of -50.80% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biofrontera AG | - | - | - | - |
| iShares Core DAX® | 0,63 % | 4,95 % | 8,66 % | 63,69 % |
| iShares Nasdaq 100 | 1,16 % | -1,16 % | 26,82 % | 89,86 % |
| iShares Nikkei 225® | 2,36 % | -1,35 % | 48,19 % | 81,68 % |
| iShares S&P 500 | 0,63 % | 1,38 % | 22,99 % | 70,25 % |
Comments by krebskrebs for this prediction
In the thread Biofrontera AG diskutieren
In the thread Trading Biofrontera AG
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten